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Empirically supported psychological treatments (ESTs) for 
anxiety disorders (AD) have shown their effi cacy and clinical 
utility, although the scope and impact of these ESTs are often 
negatively affected by premature termination of treatment (PTT) 
(Chambless & Ollendick, 2001). 
Some authors propose distinguishing dropping out of 
treatment (DT) from refusing treatment (RT) (Hatchett & Park, 
2003; Swift & Greenberg, 2012). DT refers to PTT after having 
begun treatment when the patient fails to appear without having 
reached the preset goal (according to the therapist’s judgment or to 
objective measures of clinical signifi cance; Hatchett & Park, 2003), 
or because the proposed goals were not achieved after a certain 
number of sessions (following the dose-response guidelines) 
(Bados, Balaguer, & Saldana, 2007a; Lambert, 2007; Lambert, 
Hansen, & Finch, 2001). RT refers to PTT without having started 
treatment (Swift & Greenberg, 2012).
Swift and Greenberg (2012) report a 19.7% of PTT for 
psychological treatments, compared with the 47% indicated in 
the work of Wierzbicki and Pekarik (1993) or the 43.8% of Bados 
et al. (2007a), referring to dropping out in the clinical context. 
An important point is that DT rates were higher in effectiveness 
studies (compared with effi cacy studies) and if the DT was defi ned 
by the therapist´s criteria (Swift & Greenberg, 2012). 
In AD, the rates and variables involved in PTT vary depending 
on the studies consulted. For example, Swift and Greenberg (2012), 
without distinguishing between type of study and defi nition of PTT, 
indicate dropout rates of 16.2%. Issakidis and Andrews (2004), in 
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Abstract Resumen
Background: Empirically supported psychological treatments (ESTs) 
have demonstrated their effectiveness and clinical utility for the treatment 
of anxiety disorders (AD) but few studies have assessed the factors 
associated with premature termination in ESTs for AD. Method: The 
goals of this study, which involved 291 patients with a diagnosis of anxiety 
who had received outpatient psychological care, consisted of examining 
premature termination of treatment (PTT), comparing the individual 
characteristics of the patients who successfully completed treatment with 
those who terminate it prematurely, and analyzing the predictors of PTT. 
Results: Of the sample, 8.2% refused to start treatment, 28.5% dropped 
out before completing it, and 63.2% successfully completed treatment. In 
50% of the cases, PTT occurred during the fi rst 7 sessions, and in 80%, 
before the 15th session. Alternatively, 76.4% of the patients who complete 
treatment successfully do so before session 20. We found that patients 
with PTT attended a signifi cantly lower number of treatment sessions 
and attended the sessions more irregularly and unpunctually. Presenting 
a generalized anxiety disorder (GAD), problems with punctuality and 
with task performance were predictors of failure to complete treatment. 
Conclusions: These fi ndings suggest the need to reinforce early adherence 
to treatments to help patients remain in treatment.
Keywords: Anxiety disorders, psychological treatment, dropout, rejection, 
premature termination.
Terminación prematura del tratamiento psicológico para los trastornos 
de ansiedad en el contexto clínico. Antecedentes: los tratamientos 
psicológicos empíricamente apoyados (TEAs) han demostrado utilidad 
clínica para el abordaje de los trastornos de ansiedad (TA), pero pocos 
estudios han evaluado los factores asociados a la terminación prematura 
(TPT). Método: se examinaron las tasas de TPT, sus predictores y las 
características de aquellos pacientes que terminaron prematuramente 
frente a los que completan, en una muestra de 291 pacientes, en atención 
ambulatoria y diagnosticados de algún trastorno de ansiedad. Resultados: 
el 8,2% de los participantes rechazaron comenzar el tratamiento, el 28,5% 
abandonaron antes de completarlo y el 63,2% completaron con éxito. El 
50% de los casos de TPT se produce durante las 7 primeras sesiones y en 
el 80% antes de la sesión 15. El 76,4% de los pacientes que fi nalizan con 
éxito su tratamiento lo hacen antes de la sesión 20. El grupo TPT acudió 
a un número signifi cativamente menor de sesiones y asistieron de manera 
más irregular e impuntual. Resultaron predictores de no completar el 
tratamiento presentar un Trastorno de Ansiedad Generalizada,  problemas 
de puntualidad y en la ejecución de tareas. Conclusiones: los resultados 
apuntan la necesidad de reforzar la adhesión temprana a los tratamientos 
para ayudar a los pacientes a mantenerse en los mismos.
Palabras clave: trastornos de ansiedad, tratamiento psicológico, abandono, 
rechazo, terminación prematura.
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a sample of patients diagnosed with AD in a clinical context, found 
that RT is more common (30.4% of patients do not start treatment) 
than DT (10.3% of patients drop out after starting). These results 
contrast with the 33.3% of PTT in patients with diagnoses of 
anxiety in a clinical setting, indicated by Bados, Balaguer and 
Saldaña (2007b), considering both RT and DT.
There are also important differences in outcomes and variables 
associated with PTT across studies. Some point out that, in AD, 
there is a greater likelihood of dropout than in depressive problems, 
especially if there is comorbidity between the two disorders 
(Issakidis & Andrews, 2004; Lamers et al., 2012; Pinto-Meza et 
al., 2011), whereas in other studies, AD dropout rates are lower 
than in other disorders (Bados et al., 2007a).
According to the type of diagnosis of AD, Issakidis and Andrews 
(2004) indicate a greater percentage of dropouts in patients 
diagnosed with Social phobia (30.4%), Panic with agoraphobia 
(27.9%), and generalised anxiety disorder (GAD) (34%) compared 
to the average of the sample. 
However, there is some consensus that age (lower age in 
dropouts) and the existence of comorbidity (particularly with 
depressive symptomatology) are relevant factors for PTT in AD 
(Aderka et al., 2011; Issakidis & Andrews, 2004; Lamers et al., 
2012). Lastly, in contrast to the above, several authors underline 
the diffi culty of identifying predictors of PTT in AD (Eskildsen, 
Hougaard, & Rosenberg, 2010; González, Weersing, Warnick, 
Scahill, & Woolston, 2011).
In summary, the variables associated with PTT in the 
psychological treatment of AD are confusing. In accordance 
with this, the goals of this study are: 1) to evaluate PTT for AD 
in a clinical context; (2) to compare the demographic, clinical, 
and treatment variables of patients who successfully complete 
treatment compared with those who terminate prematurely and 
fi nally; (3) to identify clinically useful predictors of completing or 
not completing treatment.
Method
Participants 
 
The sample consists of 291 patients, who had been treated at 
the University Psychology Clinic of the Universidad Complutense 
de Madrid (CUP-UCM), and who presented at least one 
diagnosis of anxiety according to the criteria of the Diagnostic 
and Statistical Manual of Mental Disorders-IV TR (American 
Psychiatric Association [APA], 2000). Participants, aged 18 or 
older, had completed their contact with the CUP-XX, either due 
to therapeutic discharge (successful completion of treatment) or to 
PTT (including DT and RT).
Instruments
Sociodemographic variables: sex, age, civil status, educational 
level, and work situation were obtained by means of an ad hoc 
questionnaire at the beginning of the intervention.
Clinical variables: diagnosis (DSM-IV-TR), comorbidity and 
duration of the problem, and the existence of previous treatments 
were obtained through the clinical interview conducted by the 
therapist, and the diagnostic instruments appropriate to each 
case; for example: the Beck Depression Inventory-II (BDI-II; 
Beck, Steer, & Brown, 1996), the Beck Anxiety Inventory (BAI; 
Beck, Epstein, Brown, & Steer, 1988; Sanz & Navarro, 2003), the 
Mobility Inventory for Agoraphobia (Chambless, Caputo, Jasin, 
Gracely, & Williams, 1985), the Penn State Worry Questionnaire 
(Meyer, Miller, Metzger, & Borkovec, 1990), the Fear of Negative 
Evaluation Scale (Watson & Friend, 1969), the Maudsley Obsessive 
-Compulsive Inventory (Hodgson, 1977) or the Fear Questionnaire 
(Mathews, Gelder, & Johnston, 1981/1986). 
Treatment variables: number of assessment and treatment 
sessions, the level of task performance (considered adequate if 
successfully completing at least 75% of the tasks assigned by 
the therapist), adequate session attendance (if at least 75% of the 
sessions were attended punctually) were obtained from the fi nal 
treatment report made by the therapist. 
Premature termination of treatment: single category of PTT 
included patients who began the assessment but refused to start 
treatment (RT) or who left before completing the treatment (DT). 
This information was obtained from the fi nal treatment report 
made by the therapist
Procedure
 
The study was conducted at the CUP-UCM, an outpatient health 
care center, considering only cases with at least one diagnosis of AD 
as the primary disorder. The characteristics of the clinic and therapists 
are described in Labrador, Estupiñá and García-Vera (2010).
In the CUP-UCM, patients are assigned to a therapist who, after 
an individualized assessment in which instruments of clinical utility 
(interviews, questionnaires, and self-registers) are used, establishes 
the formal diagnosis according to the DSM IV-TR (APA, 2000) 
requirements and designs an individualized treatment plan, based 
on the clinical case formulation and the ESTs for ADs.
The treatment, carried out in weekly 1-hour sessions, had 
a variable duration, and concluded either due to therapeutic 
discharge or dropout. The use of techniques based on ESTs for 
AD was homogeneous; the most frequent were psychoeducation, 
deactivation techniques, exposure, cognitive techniques, and 
techniques to control internal dialogue (used in 80% of the cases, 
on average). Techniques such as problem-solving and social skills 
training were used fewer (around 50% of cases).
Data analysis
Descriptive and frequency analyses were conducted to obtain 
the sociodemographic, clinical, and treatment characteristics of the 
sample of the study.
In order to analyze signifi cant differences in these variables 
between the two groups of patients , we used χ2 tests for categorical 
variables, t-tests for continuous variables, and Mann-Whitney U 
tests and Fisher’s Exact Test (FET) for the variables that did not 
meet the assumption of normality. In addition, frequency analyses 
were performed to calculate the moment at which the treatment 
was completed or prematurely terminated.
Finally, we performed binary logistic regression analysis to 
examine the predictors of completing or not completing a treatment. 
We included the sociodemographic, clinical, and therapeutic 
variables that the literature has suggested are relevant (age, sex, 
marital status, social support, employment status, diagnosis, 
comorbidity, duration of the problem, and adequate punctuality 
and task performance).
All data were analyzed using the statistical package SPSS19.
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Results
Percentages of patients who complete, reject, and drop out of 
treatment
Out of the 291 participants of the sample, 184 (63.2%) completed 
the treatment, and 107 (36.8%) terminated it prematurely. Of 
the latter, 24 patients (22.4%) refused to start treatment, and 83 
(77.6%) dropped out after having started.
Comparison of patients who complete and who prematurely 
terminate treatment 
As seen in Table 1, no statistically signifi cant differences were 
observed in the sociodemographic variables examined between 
patients who completed and those did not complete treatment.
Regarding the clinical and treatment variables (Table 2), patients 
who completed treatment received signifi cantly more treatment 
sessions (14.8) than those who did not complete treatment (8.5) (U 
= 5434, p<.001); in addition, the percentage of those who attended 
regularly and punctually was higher (90.6% compared to 72.2%; 
FET = 15.4, p<.001).
Table 3 shows the percentages of patients who completed and 
who did not complete treatment according to diagnosis. Panic 
disorder with agoraphobia was the diagnosis that obtained the 
highest percentage of patients who completed treatment (79.5%), 
and GAD obtained the lowest (53.8%). However, there were 
no signifi cant differences between the group of patients who 
completed and those who did not complete the treatment as a 
function of the diagnosis. 
 
Period in which treatment is abandoned or completed
Table 4 shows that 28.4% of the patients who dropped out 
of treatment did so before Session 5, and 75.3% did so before 
Session 15. In the sample of completers, 76.4% of the patients who 
successfully completed treatment did so before Session 20.
Predictors of PTT
Table 5 shows a logistic regression model that includes the 
variables that the literature points to as possible factors involved 
in treatment completion or dropout. The signifi cant predictors 
of failure to complete treatment—that is, rejecting treatment or 
dropping out—were not performing the tasks adequately and 
systematically (B = - 1.33, p = .01), presenting a diagnosis of GAD 
(B = 2.06, p = .02), and not adequately and punctually attending 
treatment sessions (B = - 2.18, p<.001).
Discussion
This work was conducted in clinical setting and its design 
was descriptive and retrospective. We found that 36.8% of the 
Table 1
Sociodemographic characteristics of the two groups of patients
N = 291
p†
Complete
n = 184
Do not 
complete
n = 107
Age (M ± SD) 29.8 ± 10.6 29.2 ± 11.1 .52
Sex (%)
Males
Females
26.6
73.4
29.9
70.1
.54
Civil status (%)
Without a partner
Married/partner
71.2
28.8
78.5
21.5
.17
Studies (%)
Non-University
University studies
38.8
61.2
49.5
50.5
.07
Work situation (%)
Active
Students
Other
42.4
45.7
12
37.4
53.3
9.3
.43
† level of statistical signifi cance of the χ2 tests in the case of categorical variables and t-tests 
for continuous variables. For variables that did not fulfi ll the assumption of normality, we 
used Mann-Whitney U or Fisher’s Exact Test (FET) if χ2 could not be used
* p<.05; ** p<.01; *** p<.001
Table 2
Clinical and therapeutic characteristics of the two groups of patients
N = 291
p†
Complete
n = 184
Do not complete
n = 107
Duration (months) of the problem (M ± SD) 38.3 ± 55.9 43.9 ± 46.3 .56
Comorbidity (%) 20.1 27.1 .17
Prior treatments (%) 54.4 54.3 .97
Nr. of assessment sessions (M ± SD) 3.3 (1.2) 3.5 (1.2) .20
Nr. of treatment sessions (M ± SD) 14.8 (10.5) 8.5 (9.1) <.01**
Adequate session attendance (%) (appropriate attendance and punctuality in at least 75% of sessions) 90.6 72.2 <.001***
Level of tasks performance (%) (performs correctly at least 75% of the tasks) 80.4 71.2 .08
Consumption of psychoactive drugs (%) 18.8 14.7 .40
Nr. of treatment goals (M ± SD) 7 ± 3.7 6.5 ± 4.1 .52
† level of statistical signifi cance of the χ2 tests in the case of categorical variables and t-tests for continuous variables. For variables that did not fulfi ll the assumption of normality, we used Mann-
Whitney U or Fisher’s Exact Test (FET) if χ2 could not be used
* p<.05; ** p<.01; *** p<.001
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patients in the study did not complete the treatment, which is 
higher than reported in some studies focusing on AD. It is nearly 
20 points higher than found in the meta-analysis of Swift and 
Greenberg (2012), although in this study, various types of studies 
and defi nitions of PTT are mixed. We note that the defi nition of 
PTT adopted is decisive when calculating its percentages. For 
example, in the work of Issakidis and Andrews (2004), the 10.3% 
of dropouts reported must be changed signifi cantly to 40.7%, if 
we consider the defi nition of PTT adopted in this work, because 
30.4% of the patients refused to start treatment. In Spain, Bados 
et al. (2007b), in an assistential health care context and with a 
similar defi nition of PTT (including rejections and dropouts from 
treatment), although less dependent on the therapist’s criterion 
and based more on quantitative and dose-response criteria, found 
33.3% of PTT, very similar to that obtained in this work.
In summary, PTT rates in AD vary considerably according to the 
criteria used to defi ne PTT, but when both rejections and dropouts 
from treatment are included, as in this study, the percentages seem 
to range around 35%. This aspect should be highlighted when 
comparing the outcomes because, in many works, usually referring 
to pharmacological interventions, the calculations of effi cacy or 
effectiveness only take into account patients who complete their 
protocols (analysis of completers), so their effi cacy or effectiveness 
is probably overestimated by excluding those who refuse to start or 
drop out of treatment. If these data are compared with those provided 
by studies in which patients who refuse to begin treatment or who 
drop out of treatment (intention to treat) are taken into account 
(Bados et al., 2007b), the apparent effectiveness of psychological 
treatments for AD would be penalized despite having repeatedly 
shown their effectiveness (Chambless & Ollendick, 2001).
Of the PTT, 77.6% (28.5% of the total) drop out after starting 
treatment. These percentages reveal the appropriateness of any 
action aimed at improving adherence to and/or acceptance of 
treatments, regardless of their technical aspects. Also, 22.4% 
of the patients with PTT (8.24% of the total) refused to begin 
treatment. That is, we must attend those aspects that increase early 
adherence to psychological treatments, such as therapeutic alliance, 
psychoeducational or motivational aspects (Keller, Zoellner, & 
Feeny, 2010). In fact, some studies underscore the importance 
of the fi rst sessions: (1) as an adhesion factor because the patient 
begins to perceive improvements or (2) as a facilitator of PTT in 
the absence of perceived improvements or of satisfaction with the 
obtained results (Bados et al., 2007a; Cahill et al., 2003; Howard, 
Kopta, Krause, & Orlinsky, 1986).
Table 3
Diagnosis of the two groups of patients
N = 291
p†
Complete
n = 184
Do not 
complete
n = 107
Panic disorder with agoraphobia (%)
n = 39
79.5 20.5
34
Social phobia (%)
n = 59
61 39
Specifi c phobia (%)
n = 20
55 45
Panic disorder without agoraphobia (%)
n = 39
69.2 30.8
Generalized anxiety disorder (%)
n = 26
53.8 46.2
Non-specifi c anxiety disorder (%)
n = 57
63.2 36.8
Obsessive-Compulsive Disorder (%)
n = 33
54.5 45.5
Posttraumatic stress disorder (%)
n = 18
61.1 38.9
† level of statistical signifi cance of χ2 or Fisher’s Exact Test (FET)
* p<.05; ** p<.0; *** p<.001
Table 4
Treatment period in which dropout and discharge from treatment take place
Treatment session at which patients who began treatment drop out
n = 83
n Percentage Accumulated percentage
Session 0-1 7 8.6 8.6
Session 2 2 2.5 11.1
Session 3 7 8.6 19.7
Session 4 7 8.6 28.4
Session 5 7 8.6 37
Session 6 4 4.9 42
Session 7 7 8.6 50.6
Session 8 5 6.2 56.8
Session 9 4 4.9 61.7
Session 10 2 2.5 64.2
Session 11 3 3.7 67.9
Session 12 - - 67.9
Session 13 4 4.9 72.8
Session 14 2 2.5 75.3
Session 15 3 3.7 79
Session 16 4 4.9 84
Session 17 2 2.5 86.5
Session 18 - - 86.5
Session 19 1 1.2 87.7
Session 20 1 1.2 88.9
More than 20 
sessions
9 11.1 100
Accu-
mulated 
percent-
age
Session at which treatment is completed (n = 184). Range (3-66)
Session
1-5 6-10 11-15 16-20 20-...
17.8 38 59.6 76.4 100
Table 5
Regression analysis on predictors of premature termination of treatment (PTT)
Predictors of PTT
Β P Exp (Β) R2
Adequate task performance (correctly 
performs at least 75% of the tasks)
-1.33 <.001 0.26
.20
Presenting a diagnosis of GAD 2.06 .02 7.86
Punctual session attendance (adequate 
attendance and punctuality in at least 75% 
of sessions)
-2.18 .01 8.88
Note: the variables included in the model were age, sex, marital status, social support, work 
status, diagnosis, comorbidity, duration of the problem, and level of adequate punctuality 
and task performance
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No sociodemographic differences between patients who 
completed treatment and those who did not were observed, which 
contrasts with studies fi nding that patients with PTT are younger or 
have a lower educational level (Lamers et al., 2012). 
As expected, the number of treatment sessions of patients who 
completed their treatment was higher. More relevant is the fact that 
patients who did not complete their treatments attended the sessions 
more irregularly and unpunctually. This may be of particular 
relevance, it may prematurely inform the therapist about the risk 
of therapeutic dropout, indicating the appropriateness of taking 
corrective action, such as reviewing the reasons for or justifi cation 
of the interventions, reducing the demands, or resorting more to 
psychoeducational and motivational techniques. 
Although at the level of task performance, no signifi cant 
differences were found, a trend was evident (p = .08), showing 
higher percentages of adequate task performance in patients who 
completed treatment (80.4%) versus those who did not (71.2%). 
Consequently, this value of adequate task performance, although 
not as clearly as adequate attendance, can also serve as an alarm 
signal about treatment progress, revealing the need to adapt the 
interventions. In fact, despite the benefi ts of applying contrasting 
ESTs, their rigid and little adapted application can be seen as 
impersonal and unappealing, facilitating reaching PTT to a greater 
extent than less structured treatments (based on common factors), 
as reported by some studies (Farrell & Deacon, 2016; Swan & 
Heesacker, 2013; Swift & Callahan, 2010). It seems clear that the 
care of the therapeutic alliance and the relational and motivational 
aspects must complement the technical aspects, in order to improve 
the impact and scope of ESTs. 
Although comorbidity has been frequently identifi ed as a factor 
associated with PTT (Issakidis & Andrews, 2004; Lamers et al., 
2012; Pinto-Meza et al., 2011), no signifi cant differences appeared 
between groups. Perhaps the small percentage of patients with 
comorbidity can partly explain this outcome and, moreover, in this 
work, some of the patients included in the group of non-comorbidity 
might have been included in the comorbidity group with another 
form of diagnosis. As indicated in other works (Bernaldo de Quirós 
et al., 2012), the percentages of comorbidity are lower when the 
diagnosis is established from a clinical interview (Rettew, Lynch, 
Achenbach, Dumenci, & Ivanova, 2009).
No signifi cant differences were found as a function of the 
diagnosis between the two groups of patients. The low percentage 
of completed treatments by patients presenting specifi c phobia 
(55%) is noteworthy, as this disorder achieves high success rates 
in “laboratory” settings (Wolitzky-Taylor, Horowitz, Powers, 
& Telch, 2008). The nuclearity of exposure and its “aversive” 
nature for patients (Olatunji, Deacon, & Abramowitz, 2009), 
and, especially, the low functional limitation that these problems 
usually exert in the patients’ lives may explain its high rate of PTT. 
In contrast, treatment of AD with Agoraphobia, also based on 
exposure, showed the highest percentage of completed treatments. 
Perhaps the important functional limitation that this problem 
usually produces and its effect on the patients’ motivation to 
change explain their greater adherence to treatment.
Once the treatment has started, 50% of the patients with PTT 
drop out in the fi rst 7 sessions, and 80% before the 15thsession. As 
considered above, it appears that the fi rst treatment sessions play a 
fundamental role in adherence. Alternatively, 76.4% of the patients 
who successfully complete treatment do so before session 20, 
similar percentage as proposed by Turner, Beidel, Spaulding and 
Brown (1995) or Lambert, et al. (2001) for the fi rst 14 sessions. 
These data support the thesis of dose-response, indicating a certain 
asymptotic value of the impact of psychological treatment beyond 
a certain number of sessions. 
Finally, it is important to note that the regression model shows 
that GAD is a predictor of not completing treatment, in accordance 
with the fi ndings of some studies (Issakidis & Andrews, 2004). 
GAD could imply greater “chronicity” and a more diffuse nature 
of the problem compared to other AD, which ultimately might 
interfere with the course of treatment. Both appropriate punctuality 
(arriving adequately and punctually to at least 75% of the sessions) 
and successful task completion (at least 75%) were found to be 
signifi cant predictors of treatment. These data confi rm the issues 
raised previously about the importance of attending to those factors 
that could forewarn about PTT.  
Among the limitations of the study is that, despite its clinical 
value and having been carried out in a health care context, it is 
a retrospective and descriptive study, something which limits the 
scope of the results. Methodologically structured designs could 
answer some questions that remain open, such as the patients’ 
reasons underlying the therapeutic abandonment or the role of 
the different (more or less structured) therapeutic components in 
the PPT. Furthermore, we grouped patients who refused treatment 
(RT) and those who dropped out (DT) into a single category 
(PTT) due to reduced sample size; therefore, we could not analyze 
separately the differences between the two PTT profi les. Future 
research should address this distinction, its specifi c features and 
implications in clinical practice (e.g., misapplied treatments or 
excessively long assessment sessions).
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